158 related articles for article (PubMed ID: 36576666)
1. Effect of platelet exosomes loaded with doxorubicin as a targeted therapy on triple-negative breast cancer cells.
Uslu D; Abas BI; Demirbolat GM; Cevik O
Mol Divers; 2024 Apr; 28(2):449-460. PubMed ID: 36576666
[TBL] [Abstract][Full Text] [Related]
2. Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization.
Wu YW; Lee DY; Lu YL; Delila L; Nebie O; Barro L; Changou CA; Lu LS; Goubran H; Burnouf T
Platelets; 2023 Dec; 34(1):2237134. PubMed ID: 37580876
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis.
Wei H; Chen F; Chen J; Lin H; Wang S; Wang Y; Wu C; Lin J; Zhong G
Int J Nanomedicine; 2022; 17():3483-3495. PubMed ID: 35959282
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Glioma Cells' Proliferation by Doxorubicin-Loaded Exosomes via Microfluidics.
Thakur A; Sidu RK; Zou H; Alam MK; Yang M; Lee Y
Int J Nanomedicine; 2020; 15():8331-8343. PubMed ID: 33149579
[TBL] [Abstract][Full Text] [Related]
5. Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy.
Gong C; Tian J; Wang Z; Gao Y; Wu X; Ding X; Qiang L; Li G; Han Z; Yuan Y; Gao S
J Nanobiotechnology; 2019 Sep; 17(1):93. PubMed ID: 31481080
[TBL] [Abstract][Full Text] [Related]
6. AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer.
Hosseini NF; Amini R; Ramezani M; Saidijam M; Hashemi SM; Najafi R
Biomed Pharmacother; 2022 Nov; 155():113690. PubMed ID: 36099793
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation in vitro of doxorubicin loaded mimetic exosomes-based delivery system.
Suna He -; Haofeng Pan -; Xingyue Qian -; Junyang Zhang -; Runfang Zhang -
Pak J Pharm Sci; 2023 May; 36(3):895-900. PubMed ID: 37580940
[TBL] [Abstract][Full Text] [Related]
8. A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro.
Wei H; Chen J; Wang S; Fu F; Zhu X; Wu C; Liu Z; Zhong G; Lin J
Int J Nanomedicine; 2019; 14():8603-8610. PubMed ID: 31802872
[TBL] [Abstract][Full Text] [Related]
9. Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop.
Wu YW; Huang CC; Changou CA; Lu LS; Goubran H; Burnouf T
J Biomed Sci; 2020 Mar; 27(1):45. PubMed ID: 32200762
[TBL] [Abstract][Full Text] [Related]
10. Increased anti-tumour activity by exosomes derived from doxorubicin-treated tumour cells via heat stress.
Yang Y; Chen Y; Zhang F; Zhao Q; Zhong H
Int J Hyperthermia; 2015; 31(5):498-506. PubMed ID: 25955015
[TBL] [Abstract][Full Text] [Related]
11. The effect of bovine milk lactoferrin-loaded exosomes (exoLF) on human MDA-MB-231 breast cancer cell line.
Ramezani R; Mohammadian M; Hosseini ES; Zare M
BMC Complement Med Ther; 2023 Jul; 23(1):228. PubMed ID: 37422619
[TBL] [Abstract][Full Text] [Related]
12. Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro.
Abrahams B; Gerber A; Hiss DC
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474312
[TBL] [Abstract][Full Text] [Related]
13. Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer.
Kutlehria S; Behl G; Patel K; Doddapaneni R; Vhora I; Chowdhury N; Bagde A; Singh M
AAPS PharmSciTech; 2018 Feb; 19(2):792-802. PubMed ID: 29019073
[TBL] [Abstract][Full Text] [Related]
14. Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer.
Bagheri E; Abnous K; Farzad SA; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2020 Nov; 261():118369. PubMed ID: 32882265
[TBL] [Abstract][Full Text] [Related]
15. [Discharge and Contents of Exosome from Leukocyte-Reduced Apheresis Platelet Stored for Different Storage Time].
Zhang JP; Chen BB; Zheng HH; Yang HJ; Song L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1993-1997. PubMed ID: 31839072
[TBL] [Abstract][Full Text] [Related]
16. Targeted cancer therapy using engineered exosome as a natural drug delivery vehicle.
Gomari H; Forouzandeh Moghadam M; Soleimani M
Onco Targets Ther; 2018; 11():5753-5762. PubMed ID: 30254468
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model.
Dong H; Gao M; Lu L; Gui R; Fu Y
Int J Nanomedicine; 2023; 18():3577-3593. PubMed ID: 37409026
[TBL] [Abstract][Full Text] [Related]
18. Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells.
Yu M; Gai C; Li Z; Ding D; Zheng J; Zhang W; Lv S; Li W
Cancer Sci; 2019 Oct; 110(10):3173-3182. PubMed ID: 31464035
[TBL] [Abstract][Full Text] [Related]
19. Exosome mimetics derived from bone marrow mesenchymal stem cells ablate neuroblastoma tumor in vitro and in vivo.
Li M; Wang J; Guo P; Jin L; Tan X; Zhang Z; Zhanghuang C; Mi T; Liu J; Wang Z; Wu X; Wei G; He D
Biomater Adv; 2022 Nov; 142():213161. PubMed ID: 36308859
[TBL] [Abstract][Full Text] [Related]
20. α-Tocopherol Polyethylene Glycol 1000 Succinate-Based Cationic Liposome for the Intracellular Delivery of Doxorubicin in MDA-MB-231 Triple-Negative Breast Cancer Cell Line.
Sandal P; Patel P; Singh D; Gupta GD; Kurmi BD
Assay Drug Dev Technol; 2023; 21(8):345-356. PubMed ID: 38010987
[No Abstract] [Full Text] [Related]
[Next] [New Search]
